Precision BioSciences Statistics
Want to see DTIL full AI Analyst Report?
Precision BioSciences (DTIL) Stock Statistics & Valuation Metrics
Total Valuation
Precision BioSciences has a market cap or net worth of $265.39M. The enterprise value is $117.61M.
- Market Cap
- $265.39M
- Enterprise Value
- $117.61M
Share Statistics
Precision BioSciences has 27,935,719 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 27,935,719
- Owned by Insiders
- 2.75%
- Owned by Institutions
- 18.10%
Financial Efficiency
Precision BioSciences’s return on equity (ROE) is -0.50 and return on invested capital (ROIC) is -35.47%.
- Return on Equity (ROE)
- -0.50
- Return on Assets (ROA)
- -0.30
- Return on Invested Capital (ROIC)
- -35.47%
- Return on Capital Employed (ROCE)
- -0.36
- Revenue Per Employee
- 496.58K
- Profits Per Employee
- -662.67K
- Employee Count
- 69
- Asset Turnover
- 0.22
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Precision BioSciences is -7.72. Precision BioSciences’s PEG ratio is -0.03.
- PE Ratio
- -7.72
- PS Ratio
- 5.82
- PB Ratio
- 5.03
- Price to FCF
- -5.06
- Price to Operating Cash Flow
- -5.04
- PEG Ratio
- -0.03
Income Statement
In the last 12 months, Precision BioSciences had revenue of 34.26M and earned -45.72M in profits. Earnings per share was -3.56.
- Revenue
- 34.26M
- Gross Profit
- 34.26M
- Operating Income
- -52.15M
- Pretax Income
- -46.61M
- Net Income
- -45.72M
- EBITDA
- -42.43M
- Earnings Per Share (EPS)
- -3.56
Cash Flow
In the last 12 months, operating cash flow was -51.76M and capital expenditures -52,000, giving a free cash flow of -51.81M billion.
- Operating Cash Flow
- -51.76M
- Free Cash Flow
- -51.81M
- Free Cash Flow per Share
- -1.89
Dividends & Yields
Precision BioSciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -19.06%
- Earnings Yield
- -14.26%
Stock Price Statistics
- Beta
- 0.18
- 52-Week Price Change
- 56.51%
- 50-Day Moving Average
- 6.89
- 200-Day Moving Average
- 6.69
- Relative Strength Index (RSI)
- 66.92
- Average Volume (3m)
- 315.00K
Important Dates
Precision BioSciences upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Mar 18, 2027
- Ex-Dividend Date
- ―
Financial Position
Precision BioSciences as a current ratio of 13.32, with Debt / Equity ratio of 31.23%
- Current Ratio
- 13.32
- Quick Ratio
- 13.32
- Debt to Market Cap
- 0.42
- Net Debt to EBITDA
- 1.93
- Interest Coverage Ratio
- -36.67
Taxes
In the past 12 months, Precision BioSciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Precision BioSciences EV to EBITDA ratio is -4.46, with an EV/FCF ratio of -4.21.
- EV to Sales
- 4.84
- EV to EBITDA
- -4.46
- EV to Free Cash Flow
- -4.21
- EV to Operating Cash Flow
- -4.21
Balance Sheet
Precision BioSciences has $81.85M in cash and marketable securities with $27.72M in debt, giving a net cash position of $54.13M billion.
- Cash & Marketable Securities
- $81.85M
- Total Debt
- $27.72M
- Net Cash
- $54.13M
- Net Cash Per Share
- $1.94
- Tangible Book Value Per Share
- $1.85
Margins
Gross margin is 98.71%, with operating margin of -80.27%, and net profit margin of -85.58%.
- Gross Margin
- 98.71%
- Operating Margin
- -80.27%
- Pretax Margin
- -87.54%
- Net Profit Margin
- -85.58%
- EBITDA Margin
- -108.37%
- EBIT Margin
- -113.92%
Analyst Forecast
The average price target for Precision BioSciences is $40.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $40.00
- Price Target Upside
- 321.05% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 6353.01%
- EPS Growth Forecast
- 84.80%
Scores
- Smart Score
- 8
- AI Score
- 54
